SpendMend Adds Multiple Solutions to Conductiv Agreement

SpendMend, the leading provider of solutions to optimize the cost-cycle for hospitals and healthcare networks, today announced an expansion of their solution offerings through Conductiv, the nation’s only end-to-end third-party lifecycle improvement company.

SpendMend holds the distinction as the first healthcare industry provider to have been awarded a group purchasing agreement with Conductiv Contracts. Building on several years of joint success, Conductiv is now promoting SpendMend’s Medical Device Explant Tracking, Pharmacy Spend Optimization as well as multiple 340B solutions to Conductiv’s vast nationwide membership.

“We’re always pleased to expand our catalogue of value-generating supplier solutions,” says Mickey Meehan, COO, Conductiv, “for years, we’ve recognized the consistency and quality of SpendMend’s offerings, and we’re excited to build on our successful relationship and drive additional value to our members.”

“We admire Conductiv’s unique approach, uniting an alliance of buyers and suppliers to help reshape how healthcare systems acquire services,” states Dan Geelhoed, CEO of SpendMend. “By adding more of our solutions into group purchasing agreements with Conductiv, we know we will drive more value to hospitals and ultimately that means we are helping those facilities to better fund patient care.”

The expanded solution offering is immediately available to the entire network of Conductiv member hospitals and healthcare facilities.

SourceSpendMend

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.